It has come to the Editors' attention that background information relevant to these recently published articles was incomplete and confusing. Changes of the code name of the reportedly novel immunosuppressive cyclic tetra-peptide published in The Journal of Antibiotics, November issue, 63, 633-636 (2010), and the following three articles [1] [2] [3] were not clearly explained. In addition, citations to the synthetic preparation and testing of those compounds were not included.
The code name 'AS1387392' used in these four papers represents the same compound as 'FR235225' (in papers published by the same authors in 2007 and 2008 4, 5 ) and 'WF27082E' (in the patent 'WO/ 2000/021979' published in 2000 6 ). This fermentation-derived compound is also identical to LGP1 that was prepared by total synthesis. 7 The closely related natural product 'FR235222' was earlier reported in papers published in 2003 8, 9 and as 'WF27082B' in the above mentioned patent 'WO/2000/021979' . 6 This code name of FR235222 has not changed.
In addition, the authors of the above four articles cited only the references that were limited to the natural products. However, the references that reported the synthetic endeavors 7, [10] [11] [12] to prepare analogs as better inhibitors of histone deacetylase also should have been included.
The journal apologizes to the readership for the confusion caused by the changes of the code names and the lack of citation of the earlier references during the review process.
